Synergistic effects of anti-MRSA herbal extracts combined with antibiotics

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Edwards B, Andini R, Esposito S et al. Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: where are we now? J. Glob. Antimicrob. Resist. 2(3), 133–140 (2014). • Describes what MRSA is and what damage MRSA can cause.
  Medline CASGoogle Scholar
• 2. Ahmadi M. Investigation of antibacterial effect of cadmium oxide nanoparticles on Staphylococcus aureus bacteria. J. Nanobiotechnol. 12(1), 26 (2014).
  MedlineGoogle Scholar
• 3. Gurieva TV, Bootsma MC, Bonten MJ. Decolonization of patients and health care workers to control nosocomial spread of methicillin-resistant Staphylococcus aureus: a simulation study. BMC Infect. Dis. 12, 302 (2012).
  MedlineGoogle Scholar
• 4. Peacock SJ, Paterson GK. Mechanisms of methicillin resistance in Staphylococcus aureus. Annu. Rev. Biochem. 84, 577–601 (2015).
  Medline CASGoogle Scholar
• 5. Groves MD, Crouch B, Coombs GW et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated from Australian veterinarians. PLoS ONE 11(1), e0146034 (2016).
  MedlineGoogle Scholar
• 6. Piatkowska E, Piatkowski J, Przondo-Mordarska A. The strongest resistance of Staphylococcus aureus to erythromycin is caused by decreasing uptake of the antibiotic into the cells. Cell Mol. Biol. Lett. 17(4), 633–645 (2012).
  Medline CASGoogle Scholar
• 7. Ramirez MS, Tolmasky ME. Aminoglycoside modifying enzymes. Drug Resist. Updat. 13(6), 151–171 (2010).
  Medline CASGoogle Scholar
• 8. Van Bambeke F, Balzi E, Tulkens PM. Antibiotic efflux pumps. Biochem. Pharmacol. 60(4), 457–470 (2000).
  Medline CASGoogle Scholar
• 9. Aucken HM, Ganner M, Murchan S, Cookson BD, Johnson AP. A new UK strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-17) resistant to multiple antibiotics. J. Antimicrob. Chemother. 50(2), 171–175 (2002).
  Medline CASGoogle Scholar
• 10. Roberts MC, Schwarz S, Aarts HJ. Erratum: acquired antibiotic resistance genes: an overview. Front. Microbiol. 3, 384 (2012).
  MedlineGoogle Scholar
• 11. Wootton M, Howe RA, Walsh TR, Bennett PM, MacGowan AP. In vitro activity of 21 antimicrobials against vancomycin-resistant Staphylococcus aureus (VRSA) and heteroVRSA (hVRSA). J. Antimicrob. Chemother. 50(5), 760–761 (2002). • Introduces that vancomycin is the first-line drug for the treatment of MRSA infection-related diseases.
  Medline CASGoogle Scholar
• 12. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40(1), 135–136 (1997).
  Medline CASGoogle Scholar
• 13. Hiramatsu K, Aritaka N, Hanaki H et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350(9092), 1670–1673 (1997).
  Medline CASGoogle Scholar
• 14. Deng Y, Yu Y, Luo H, Zhang M, Qin X, Li L. Antimicrobial activity of extract and two alkaloids from traditional Chinese medicinal plant Stephania dielsiana. Food Chem. 124(4), 1556–1560 (2011).
  CASGoogle Scholar
• 15. Zuo GY, Zhang XJ, Yang CX, Han J, Wang GC, Bian ZQ. Evaluation of traditional Chinese medicinal plants for anti-MRSA activity with reference to the treatment record of infectious diseases. Molecules 17(3), 2955–2967 (2012).
  Medline CASGoogle Scholar
• 16. Zuo GY, Wang GC, Zhao YB et al. Screening of Chinese medicinal plants for inhibition against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). J. Ethnopharmacol. 120(2), 287–290 (2008).
  Medline CASGoogle Scholar
• 17. Gibbons S. Anti-staphylococcal plant natural products. Nat. Prod. Rep. 21(2), 263–277 (2004). •• Specifies the inhibitory effect of natural products on MRSA.
  Medline CASGoogle Scholar
• 18. Abreu AC, Mcbain AJ, Simoes M. Plants as sources of new antimicrobials and resistance-modifying agents. Nat. Prod. Rep. 29(9), 1007–1021 (2012).
  Medline CASGoogle Scholar
• 19. Sharifirad J. Phytochemical screening and antibacterial activity of different parts of the Prosopis farcta extracts against methicillin-resistant Staphylococcus aureus (MRSA). Minerva Biotecnol. 26(4), 287–293 (2014). • The inhibitory effect of extracts from different parts of natural products on MRSA was different.
  Google Scholar
• 20. Silva JaTD. Chemical composition, antioxidant activity and in vitro antibacterial activity ofAchillea wilhelmsiiC. Koch essential oil on methicillin-susceptible and methicillin-resistant Staphylococcus aureus spp. Biotech 5(1), 39–44 (2015).
  Google Scholar
• 21. Chung PY, Navaratnam P, Chung LY. Synergistic antimicrobial activity between pentacyclic triterpenoids and antibiotics against Staphylococcus aureus strains. Ann. Clin. Microbiol. Antimicrob. 10(1), 25–25 (2011).
  Medline CASGoogle Scholar
• 22. Fischbach MA. Combination therapies for combating antimicrobial resistance. Curr. Opin. Microbiol. 14(5), 519–523 (2011). •• Suggests that combination therapy is a promising strategy to combat MRSA.
  Medline CASGoogle Scholar
• 23. Brehm-Stecher BF, Johnson EA. Sensitization of Staphylococcus aureus and Escherichia coli to antibiotics by the sesquiterpenoids nerolidol, farnesol, bisabolol, and apritone. Antimicrob. Agents Chemother. 47(10), 3357–3360 (2003).
  Medline CASGoogle Scholar
• 24. Grande MJ, Lopez RL, Abriouel H et al. Treatment of vegetable sauces with enterocin AS-48 alone or in combination with phenolic compounds to inhibit proliferation of Staphylococcus aureus. J. Food Prot. 70(2), 405–411 (2007).
  Medline CASGoogle Scholar
• 25. Braga LC, Leite AA, Xavier KG et al. Synergic interaction between pomegranate extract and antibiotics against Staphylococcus aureus. Can. J. Microbiol. 51(7), 541–547 (2005).
  Medline CASGoogle Scholar
• 26. Hemaiswarya S, Kruthiventi AK, Doble M. Synergism between natural products and antibiotics against infectious diseases. Phytomedicine 15(8), 639–652 (2008). •• Suggests that the combination of traditional Chinese medicine and Western medicine can play a synergistic antibacterial effect.
  Medline CASGoogle Scholar
• 27. Sharifi-Rad J, Mnayer D, Roointan A et al. Antibacterial activities of essential oils from Iranian medicinal plants on extended-spectrum β-lactamase-producing Escherichia coli. Cell. Mol. Biol. 62(9), 75–82 (2016).
  Medline CASGoogle Scholar
• 28. Foster TJ. Can β-lactam antibiotics be resurrected to combat MRSA? Trends Microbiol. 27(1), 26–38 (2018).
  MedlineGoogle Scholar
• 29. Chambers HF, Deleo FR. Waves of resistance: staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7(9), 629–641 (2009).
  Medline CASGoogle Scholar
• 30. Yu HH, Kim KJ, Cha JD et al. Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. J. Med. Food. 8(4), 454–461 (2005).
  Medline CASGoogle Scholar
• 31. Liu IX, Durham DG, Richards RM. Baicalin synergy with beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus and other beta-lactam-resistant strains of S. aureus. J. Pharm. Pharmacol. 52(3), 361 (2000).
  Medline CASGoogle Scholar
• 32. Zuo GY, An J, Han J et al. Isojacareubin from the Chinese Herb hypericum japonicum: potent antibacterial and synergistic effects on clinical methicillin-resistant Staphylococcus aureus (MRSA). Int. J. Mol. Sci. 13(7), 8210–8218 (2012).
  Medline CASGoogle Scholar
• 33. Basri DF, Sandra V. Synergistic interaction of methanol extract from canarium odontophyllum miq. leaf in combination with oxacillin against methicillin-resistant Staphylococcus aureus (MRSA) ATCC 33591. Int. J. Microbiol. 99(11), E2317–E2324 (2014).
  Google Scholar
• 34. Hassan SM, Haq AU, Byrd JA, Berhow MA, Cartwright AL, Bailey CA. Haemolytic and antimicrobial activities of saponin-rich extracts from guar meal. Food Chem. 119(2), 600–605 (2010).
  CASGoogle Scholar
• 35. Mun SH, Lee YS, Han SH et al. In vitro potential effect of morin in the combination with β-lactam antibiotics against methicillin-resistant Staphylococcus aureus. Foodborne Pathog. Dis. 12(6), 545–550 (2015).
  Medline CASGoogle Scholar
• 36. Zeng CH, Yang K, Ming-Guang XU, Guang WU, Chen YQ, Zhong ZG. In vitro antibiotic activities of total flavonoids from guangxi ampelopsis grossedentata in combination with β-lactam antibiotics. Herald Med. 2013(3), 9 (2013).
  Google Scholar
• 37. Catteau L, Reichmann NT, Olson J et al. Synergy between ursolic and oleanolic acids from vitellaria paradoxa leaf extract and β-lactams against methicillin-resistant Staphylococcus aureus: in vitro and in vivo activity and underlying mechanisms. Molecules 22(12), 2245 (2017).
  Google Scholar
• 38. Wang CM, Chen HT, Wu ZY, Jhan YL, Shyu CL, Chou CH. Antibacterial and synergistic activity of pentacyclic triterpenoids isolated from Alstonia scholaris. Molecules (Basel, Switzerland) 21(2), 139 (2016).
  MedlineGoogle Scholar
• 39. Hu ZQ, Zhao WH, Hara Y, Shimamura T. Epigallocatechin gallate synergy with ampicillin/sulbactam against 28 clinical isolates of methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 48(3), 361–364 (2001).
  Medline CASGoogle Scholar
• 40. Shiota S, Shimizu M, Mizushima T et al. Marked reduction in the minimum inhibitory concentration (MIC) of beta-lactams in methicillin-resistant Staphylococcus aureus produced by epicatechin gallate, an ingredient of green tea (Camellia sinensis). Biol. Pharm. Bull. 22(12), 1388–1390 (1999).
  Medline CASGoogle Scholar
• 41. Shiota S, Shimizu M, Sugiyama J, Morita Y, Mizushima T, Tsuchiya T. Mechanisms of action of corilagin and tellimagrandin I that remarkably potentiate the activity of beta-lactams against methicillin-resistant Staphylococcus aureus. Microbiol. Immunol. 48(1), 67–73 (2004).
  Medline CASGoogle Scholar
• 42. Shiota S, Shimizu M, Mizusima T et al. Restoration of effectiveness of beta-lactams on methicillin-resistant Staphylococcus aureus by tellimagrandin I from rose red. FEMS Microbiol. Lett. 185(2), 135–138 (2000).
  Medline CASGoogle Scholar
• 43. Harnett N, Brown S, Krishnan C. Emergence of quinolone resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Ontario, Canada. Antimicrob. Agents Chemother. 35(9), 1911–1913 (1991).
  Medline CASGoogle Scholar
• 44. Bebear CM, Renaudin J, Charron A et al. Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis. Antimicrob. Agents Chemother. 43(4), 954 (1999).
  Medline CASGoogle Scholar
• 45. Toshinobu H, Yasuhiro S, Akio M et al. Detection of mutations in quinolone resistance-determining regions in levofloxacin- and methicillin-resistant Staphylococcus aureus: effects of the mutations on fluoroquinolone MICs. Diagn. Microbiol. Infect. Dis. 46(2), 139–145 (2003).
  MedlineGoogle Scholar
• 46. Spigaglia P, Barbanti F, Louie T, Barbut F, Mastrantonio P. Molecular analysis of the gyrA and gyrB quinolone resistance-determining regions of fluoroquinolone-resistant Clostridium difficile mutants selected in vitro. Antimicrob. Agents Chemother. 53(6), 2463–2468 (2009).
  Medline CASGoogle Scholar
• 47. Stavri M, Piddock LJ, Gibbons S. Bacterial efflux pump inhibitors from natural sources. J. Antimicrob. Chemother. 59(6), 1247–1260 (2007).
  Medline CASGoogle Scholar
• 48. Piddock LJ. Multidrug-resistance efflux pumps – not just for resistance. Nat. Rev. Microbiol. 4(8), 629–636 (2006).
  Medline CASGoogle Scholar
• 49. Piddock LJ. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19(2), 382–402 (2006).
  Medline CASGoogle Scholar
• 50. Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc. Natl Acad. Sci. USA 97(4), 1433–1437 (2000).
  Medline CASGoogle Scholar
• 51. Costa SS, Sobkowiak B, Parreira R et al. Genetic diversity of norA, Coding for a main efflux pump of Staphylococcus aureus. Front. Genet. 9, 710 (2018).
  Medline CASGoogle Scholar
• 52. Yu JL, Grinius L, Hooper DC. NorA functions as a multidrug efflux protein in both cytoplasmic membrane vesicles and reconstituted proteoliposomes. J. Bacteriol. 184(5), 1370–1377 (2002).
  Medline CASGoogle Scholar
• 53. Trucksis M, Wolfson JS, Hooper DC. A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus. J. Bacteriol. 173(18), 5854–5860 (1991).
  Medline CASGoogle Scholar
• 54. Noguchi N, Okada H, Narui K, Sasatsu M. Comparison of the nucleotide sequence and expression of norA genes and microbial susceptibility in 21 strains of Staphylococcus aureus. Microb. Drug Resist. 10(3), 197–203 (2004).
  Medline CASGoogle Scholar
• 55. Uddin MJ, Ahn J. Associations between resistance phenotype and gene expression in response to serial exposure to oxacillin and ciprofloxacin in Staphylococcus aureus. Lett. Appl. Microbiol. 65(6), 462–468 (2017).
  Medline CASGoogle Scholar
• 56. Sundaramoorthy NS, Mitra K, Ganesh JS et al. Ferulic acid derivative inhibits NorA efflux and in combination with ciprofloxacin curtails growth of MRSA in vitro and in vivo. Microb. Pathog. 124, 54–62 (2018).
  Medline CASGoogle Scholar
• 57. Chan BC, Ip M, Lau CB et al. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase. J. Ethnopharmacol. 137(1), 767–773 (2011).
  Medline CASGoogle Scholar
• 58. Yang ZC, Wang BC, Yang XS, Wang Q, Ran L. The synergistic activity of antibiotics combined with eight traditional Chinese medicines against two different strains of Staphylococcus aureus. Colloids Surf. B. Biointerfaces 41(2), 79–81 (2005).
  Medline CASGoogle Scholar
• 59. Norihisa N, Hiroyuki O, Koji N, Masanori S. Comparison of the nucleotide sequence and expression of norA genes and microbial susceptibility in 21 strains of Staphylococcus aureus. Microb. Drug Resist. 10(3), 197–203 (2004).
  MedlineGoogle Scholar
• 60. Costa SS, Viveiros M, Amaral L, Couto I. Multidrug efflux pumps in Staphylococcus aureus: an update. Open Microbiol. J. 7, 59–71 (2013).
  MedlineGoogle Scholar
• 61. Khan IA, Mirza ZM, Kumar A, Verma V, Qazi GN. Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus. Antimicrob. Agents Chemother. 50(2), 810–812 (2006).
  Medline CASGoogle Scholar
• 62. Gibbons S, Oluwatuyi M, Kaatz GW. A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus. J. Antimicrob. Chemother. 51(1), 13–17 (2003).
  Medline CASGoogle Scholar
• 63. Bernard FX, Sablé S, Cameron B et al. Glycosylated flavones as selective inhibitors of topoisomerase IV. Antimicrob. Agents Chemother. 41(5), 992–998 (1997).
  Medline CASGoogle Scholar
• 64. Liu MH, Otsuka N, Noyori K et al. Synergistic effect of kaempferol glycosides purified from Laurus nobilis and fluoroquinolones on methicillin-resistant Staphylococcus aureus. Biol. Pharm. Bull. 32(3), 489–492 (2009).
  Medline CASGoogle Scholar
• 65. Bernd B, Cooper MA. Aminoglycoside antibiotics in the 21st century. ACS Chem. Biol. 8(1), 105 (2013).
  MedlineGoogle Scholar
• 66. Nakazawa H, Kikuchi Y, Honda T, Isago T, Nozaki M. Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycin. J. Infect. Chemother. 9(4), 304–309 (2003).
  Medline CASGoogle Scholar
• 67. Adwan GM, Abushanab BA, Adwan KM. In vitro activity of certain drugs in combination with plant extracts against Staphylococcus aureus infections. African J. Biotechnol. 8(17), 4239–4241 (2009).
  CASGoogle Scholar
• 68. Lee YS, Kang OH, Choi JG et al. Synergistic effects of the combination of galangin with gentamicin against methicillin-resistant Staphylococcus aureus. J. Microbiol. 46(3), 283–288 (2008).
  Medline CASGoogle Scholar
• 69. Kim ES, Jeong SI, Kim JH et al. Synergistic effects of the combination of 20-hydroxyecdysone with ampicillin and gentamicin against methicillin-resistant Staphylococcus aureus. J. Microbiol. Biotechnol. 19(12), 1576–1581 (2009).
  Medline CASGoogle Scholar
• 70. Guo Y, Wu Y, Chen W, Lin J. Endotoxic damage to the stria vascularis: the pathogenesis of sensorineural hearing loss secondary to otitis media? J. Laryngol. Otol. 108(4), 310–313 (1994).
  Medline CASGoogle Scholar
• 71. Mates SM, Eisenberg ES, Mandel LJ, Patel L, Kaback HR, Miller MH. Membrane potential and gentamicin uptake in Staphylococcus aureus. Proc. Natl Acad. Sci. USA 79(21), 6693–6697 (1982).
  Medline CASGoogle Scholar
• 72. Vázquez NM, Fiorilli G, Guido PaC, Moreno S. Carnosic acid acts synergistically with gentamicin in killing methicillin-resistant Staphylococcus aureus clinical isolates. Phytomedicine 23(12), 1337–1343 (2016).
  Medline CASGoogle Scholar
• 73. Teng Z, Li M, Shi D, Deng X, Wang J. Synergistic interactions of cryptotanshinone and aminoglycoside antibiotics against Staphylococcus aureus in vitro. J. Glob. Antimicrob. Resist. 13, 264–265 (2018).
  MedlineGoogle Scholar
• 74. Cha JD, Lee JH, Choi KM, Choi SM, Park JH. Synergistic effect between cryptotanshinone and antibiotics against clinic methicillin and vancomycin-resistant Staphylococcus aureus. Evid. Based Complement. Alternat. Med. 2014, 450572 (2014). • Indicates synergistic properties of glycopeptide antibiotic combined with herbal extract against MRSA.
  MedlineGoogle Scholar
• 75. Zuo GY, Han ZQ, Hao XY, Han J, Li ZS, Wang GC. Synergy of aminoglycoside antibiotics by 3-Benzylchroman derivatives from the Chinese drug Caesalpinia sappan against clinical methicillin-resistant Staphylococcus aureus (MRSA). Phytomedicine 21(7), 936–941 (2014).
  Medline CASGoogle Scholar
• 76. Xu HX, Lee SF. The antibacterial principle of Caesalpina sappan. Phytother. Res. 18(8), 647–651 (2010).
  Google Scholar
• 77. Ball PR, Shales SW, Chopra I. Plasmid-mediated tetracycline resistance in escherichia coli involves increased efflux of the antibiotic. Biochem. Biophys. Res. Commun. 93(1), 74–81 (1980).
  Medline CASGoogle Scholar
• 78. Khan SA, Novick RP. Complete nucleotide sequence of pT181, a tetracycline-resistance plasmid from Staphylococcus aureus. Plasmid 10(3), 251–259 (1983).
  Medline CASGoogle Scholar
• 79. Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 65(2), 232–260 (2001).
  Medline CASGoogle Scholar
• 80. Connell SR, Tracz DM, Nierhaus KH, Taylor DE. Ribosomal protection proteins and their mechanism of tetracycline resistance. Antimicrob. Agents Chemother. 47(12), 3675 (2003).
  Medline CASGoogle Scholar
• 81. Burdett V. Tet(M)-promoted release of tetracycline from ribosomes is GTP dependent. J. Bacteriol. 178(11), 3246 (1996).
  Medline CASGoogle Scholar
• 82. Mai F, Sumiko S, Teruo K et al. Remarkable synergies between baicalein and tetracycline, and baicalein and beta-lactams against methicillin-resistant Staphylococcus aureus. Microbiol. Immunol. 49(4), 391–396 (2013).
  Google Scholar
• 83. Novy P, Urban J, Leuner O, Vadlejch J, Kokoska L. In vitro synergistic effects of baicalin with oxytetracycline and tetracycline against Staphylococcus aureus. J. Antimicrob. Chemother. 66(6), 1298 (2011). • Indicates synergistic antimicrobial effect of tetracycline combined with herbal extract against MRSA.
  Medline CASGoogle Scholar
• 84. Kurek A, Nadkowska P, Pliszka S, Wolska KI. Modulation of antibiotic resistance in bacterial pathogens by oleanolic acid and ursolic acid. Phytomedicine 19(6), 515–519 (2012).
  Medline CASGoogle Scholar
• 85. Bonvicini F, Mandrone M, Antognoni F, Poli F, Angela Gentilomi G. Ethanolic extracts of Tinospora cordifolia and Alstonia scholaris show antimicrobial activity towards clinical isolates of methicillin-resistant and carbapenemase-producing bacteria. Nat. Prod. Res. 28(18), 1438–1445 (2014).
  Medline CASGoogle Scholar
• 86. Kumiko H, Sumiko S, Tsutomu H, Takashi Y, Teruo K, Tomofusa T. Antimicrobial activity of oleanolic acid from Salvia officinalis and related compounds on vancomycin-resistant enterococci (VRE). Biol. Pharm. Bull. 30(6), 1147–1149 (2007).
  MedlineGoogle Scholar
• 87. hdullah S, Kakru DK, Thoker MA, Bhat FA, Hussain N, Shah A. Emergence of low level vancomycin resistance in MRSA. Indian J. Med. Microbiol. 21(3), 196–198 (2003).
  MedlineGoogle Scholar
• 88. Kollef M. Limitations of vancomycin in the management of resistant staphylococcal infections. Clin. Infect. Dis. 45(3), 191–195 (2007).
  Google Scholar
• 89. van Hal SJ, Lodise TP, Paterson DL. The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin. Infect. Dis. 54(6), 755–771 (2012).
  Medline CASGoogle Scholar
• 90. Bruniera FR, Ferreira FM, Saviolli LR et al. The use of vancomycin with its therapeutic and adverse effects: a review. Eur. Rev. Med. Pharmacol. Sci. 19(4), 694–700 (2015).
  Medline CASGoogle Scholar
• 91. Leandro DL, Beatriz B, Laila M. Antimicrobial activity of 6-oxophenolic triterpenoids. Mode of action against Bacillus subtilis. Planta Med. 71(04), 313–319 (2005).
  MedlineGoogle Scholar
• 92. Walencka E, Rozalska S, Wysokinska H, Rozalski M, Kuzma L, Rozalska B. Salvipisone and aethiopinone from Salvia sclarea hairy roots modulate staphylococcal antibiotic resistance and express anti-biofilm activity. Planta Med. 73(06), 545–551 (2007).
  Medline CASGoogle Scholar
• 93. Feng H, Xiang H, Zhang J et al. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to Cryptotanshinone. Biomed. Res. Int. 2009(1110–7243), 617509 (2009).
  Google Scholar